- Home
- NTNX vs PODD Comparison
NTNX vs PODD Comparison
Compare NTNX & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTNX
- PODD
- Stock Information
- Founded
- NTNX 2009
- PODD 2000
- Country
- NTNX United States
- PODD United States
- Employees
- NTNX N/A
- PODD N/A
- Industry
- NTNX Computer Software: Prepackaged Software
- PODD Medical/Dental Instruments
- Sector
- NTNX Technology
- PODD Health Care
- Exchange
- NTNX Nasdaq
- PODD Nasdaq
- Market Cap
- NTNX 19.3B
- PODD 16.5B
- IPO Year
- NTNX 2016
- PODD 2007
- Fundamental
- Price
- NTNX $69.74
- PODD $282.80
- Analyst Decision
- NTNX Buy
- PODD Buy
- Analyst Count
- NTNX 14
- PODD 16
- Target Price
- NTNX $79.50
- PODD $291.81
- AVG Volume (30 Days)
- NTNX 1.7M
- PODD 574.3K
- Earning Date
- NTNX 02-26-2025
- PODD 02-20-2025
- Dividend Yield
- NTNX N/A
- PODD N/A
- EPS Growth
- NTNX N/A
- PODD 96.40
- EPS
- NTNX N/A
- PODD 5.78
- Revenue
- NTNX $2,228,718,000.00
- PODD $2,071,600,000.00
- Revenue This Year
- NTNX $16.72
- PODD $23.56
- Revenue Next Year
- NTNX $16.51
- PODD $18.07
- P/E Ratio
- NTNX N/A
- PODD $48.93
- Revenue Growth
- NTNX 14.86
- PODD 22.07
- 52 Week Low
- NTNX $43.35
- PODD $160.19
- 52 Week High
- NTNX $75.80
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- NTNX 52.63
- PODD 54.94
- Support Level
- NTNX $69.31
- PODD $270.00
- Resistance Level
- NTNX $72.46
- PODD $288.95
- Average True Range (ATR)
- NTNX 1.83
- PODD 6.83
- MACD
- NTNX -0.09
- PODD -0.31
- Stochastic Oscillator
- NTNX 52.78
- PODD 65.78
About NTNX Nutanix Inc.
Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data, anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company is into a single operating and reportable segment that is subscription-based business model. Key revenue is generated from United States.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.